As of 2024-12-15, the Fair Value of Reata Pharmaceuticals Inc (RETA) is -13.04 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 172.36 USD, the upside of Reata Pharmaceuticals Inc is -107.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -80.55 | -290.17 | -247.75 | -297.39 | -311.90 | -245.55 |
| YoY growth | -68.97% | -260.24% | 14.62% | -20.03% | -4.88% | -67.90% |
| Market Cap (mil) | 5,789.16 |
| P/E | |
| Forward P/E | -66.10x |
| EPS | -2.61 |
| Avg earnings growth rate | -67.90% |
| TTM earnings | -87.62 |